Sees Q1 gross margin 51%. Sees Q1 sales in the United States of approximately $144M to $147M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNDM:
- Tandem Diabetes reports Q4 EPS 1c, consensus (24c)
- Tandem Diabetes Care: Positioned for Growth with FDA Approval of Control IQ+
- FDA clears Tandem’s Control-IQ+ for type 2 diabetes treatment
- TNDM Upcoming Earnings Report: What to Expect?
- Tandem Diabetes price target raised to $44 from $42 at Bernstein